Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.35    -0.10 (-0.61%)
Bid:
16.30
Ask:
16.45
Spread: 0.15 (0.92%)
Market Cap: £131.05m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Replacement Form 8 (OPD) Offeree

14 Oct 2014 10:10

RNS Number : 2307U
Allocate Software PLC
14 October 2014
 



 

 

Correction: Amendment to Section 3 of RNS 2086U replacing incorrect reference to Acorn Shares with Allocate Shares and Acorn Director with Allocate Director.

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Allocate Software Plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Allocate Software Plc

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEREE

(e) Date position held:

14 October 2014

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

If YES, specify which:

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

5 pence Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

-

-

-

-

(2) Derivatives (other than options):

-

-

-

-

(3) Options and agreements to purchase/sell:

-

-

-

-

 

TOTAL:

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

Shares

Name

Number of Allocate shares¹

% of issued ordinary share capital of Allocate as at 14 October 2014

Terry Osborne

403,517

0.59

Ian Bowles

802,730

1.18

Chris Gale

65,429

0.10

Allen Swann

276,118

0.40

Richard King

50,000

0.07

Andrew Pringle

7,190

0.01

Total

1,604,984

2.35

 

 

¹. This number includes the number of Allocate Shares (if any) held by family members/trusts/nominees of the relevant Allocate Director to which the irrevocable also relates.

 

Options

 

Name

Name of share scheme

Number of shares

Grant date

Exercise price

Normal exercise period

Ian Bowles

LTRP

LTRP

LTRP

Bonus Option Scheme

 

400,000

300,000

300,000

150,000

1 December 2011

1 December 2011

1 December 2011

17 March 2014

Nil

Nil

Nil

116.5

10/14 - 30/11/17

09/15 - 30/11/17

09/16 - 30/11/17

17/03/15 - 16/03/24

Chris Gale

New CSOP

New Unapproved Option Scheme

 

27,972

105,361

15 August 2012

15 August 2012

71.5

71.5

09/15 - 14/08/22

09/15 - 14/08/22

 

Allen Swann

Bonus Option Scheme

New CSOP

New Unapproved Option Scheme

New Unapproved Option Scheme

 

50,000

 

27,972

105,361

 

50,000

17 March 2014

 

15 August 2012

15 August 2012

 

17 March 2014

 

116.5

 

71.5

71.5

 

116.5

17/03/15 - 16/03/24

 

09/15 - 14/08/22

09/15 - 14/08/22

 

09/16 - 16/03/24

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

14 October 2014

Contact name:

Chris Gale - Chief Financial Officer

 

Telephone number:

+44 (0) 20 7355 5555

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEEANELFELLFEF
Date   Source Headline
28th Nov 20137:00 amRNSBoard Appointment
26th Nov 20133:27 pmRNSResult of AGM and Scrip Dividend Scheme
14th Nov 20135:34 pmRNSScrip Dividend Scheme
6th Nov 20137:00 amRNSDirector/PDMR Shareholding
4th Nov 20134:50 pmRNSBlocklisting Application
4th Nov 201311:28 amRNSDirector/PDMR Shareholding
4th Nov 201310:06 amRNSNotification of Major Interest in Shares
4th Nov 20139:29 amRNSChange of Registered Office
4th Nov 20137:00 amRNSNotification of Major Interest in Shares
28th Oct 20133:15 pmRNSDirector/PDMR Shareholding
25th Oct 20139:15 amRNSNotification of Major Interest in Shares
21st Oct 20132:17 pmRNSNotice of AGM
21st Oct 20137:00 amRNSNotification of Major Interest in Shares
8th Oct 20133:24 pmRNSDirector/PDMR Shareholding
8th Oct 201311:39 amRNSNotification of Major Interest in Shares
7th Oct 20137:11 amRNSNotification of Major Interest in Shares
7th Oct 20137:00 amRNSBlocklisting Application
2nd Oct 201312:55 pmRNSExercise of Share Options
1st Oct 20133:29 pmRNSNotification of Major Interest in Shares
30th Sep 20135:17 pmRNSNotification of Major Interest in Shares
30th Sep 20139:46 amRNSNotification of Major Interest in Shares
30th Sep 20137:00 amRNSNotification of Major Interest in Shares
23rd Sep 20131:28 pmRNSNotification of Major Interest in Shares
23rd Sep 20137:09 amRNSRetirement of Director & Director Shareholding
23rd Sep 20137:05 amRNSExercise of Options & Director/PDMR Shareholding
20th Sep 20137:00 amRNSExercise of Share Options
18th Sep 20132:53 pmRNSDirector Shareholding
28th Aug 20137:00 amRNSExercise of Share Options
9th Aug 20139:01 amRNSExercise of Share Options
2nd Aug 20133:18 pmRNSExercise of Share Options
31st Jul 20131:30 pmRNSDividend Payment Date
23rd Jul 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSTrading Update
20th May 201310:19 amRNSExercise of Options
15th May 20131:08 pmRNSNotification of Major Interest in Shares
7th May 201310:25 amRNSExercise of Options
2nd May 20139:26 amRNSExercise of Options
29th Apr 20138:31 amRNSExercise of Options
26th Apr 20139:49 amRNSExercise of Options
27th Mar 20135:06 pmRNSExercise of Options
25th Mar 20133:30 pmRNSNotification of Major Interest in Shares
25th Mar 20137:05 amRNSNotification of Major Interest In Shares
22nd Mar 20132:16 pmRNSExercise of Options
6th Mar 20134:30 pmRNSHolding(s) in Company
6th Mar 20132:08 pmRNSHolding(s) in Company
26th Feb 20131:12 pmRNSExercise of Options
11th Feb 201310:59 amRNSHolding(s) in Company
11th Feb 201310:53 amRNSHolding(s) in Company
11th Feb 201310:51 amRNSHolding(s) in Company
5th Feb 20137:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.